Dominick Conde analyzes the Supreme Court’s January 20th, 2015 decision in Teva Pharmaceuticals v. Sandoz, which overturned the Federal Circuit’s de novo standard of review for district court claim constructions, and its implications on future patent litigations.
March 2015 | Intellectual Property Today
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.: Where Does Claim Construction Go From Here?
1 min
Related Services
Related Insights
New Dance Moves? Purple Book Amendments Require Public Disclosure of ‘Patent Dance’ Patent Lists
New Dance Moves? Purple Book Amendments Require Public Disclosure of ‘Patent Dance’ Patent Lists
July 12, 2021
1min
Supreme Court Upholds and Limits Assignor Estoppel in Patent Cases
Supreme Court Upholds and Limits Assignor Estoppel in Patent Cases
June 29, 2021
4min
Supreme Court Holds That Authority Exercised by Administrative Patent Judges in IPRs Is Unconstitutional and Provides for Director Review of IPR Decisions as a Remedy
Supreme Court Holds That Authority Exercised by Administrative Patent Judges in IPRs Is Unconstitutional and Provides for Director Review of IPR Decisions as a Remedy
June 21, 2021
6min
Events
Creating Pathways to Diversity® Conference
Creating Pathways to Diversity® Conference
October 11, 2021 Minority Corporate Counsel Association
Recent News
For the Record Quotes Juliana Reno on Sharing Protected Health Information with Law Enforcement
For the Record Quotes Juliana Reno on Sharing Protected Health Information with Law Enforcement
September 17, 2021
2min
IPWatchdog Quotes Justin Oliver on the Impact of the America Invents Act
IPWatchdog Quotes Justin Oliver on the Impact of the America Invents Act
September 17, 2021
2min
Jeffrey Sabin Awarded 2021 Small Company Turnaround/Transaction of the Year Award by the Turnaround Management Association
Jeffrey Sabin Awarded 2021 Small Company Turnaround/Transaction of the Year Award by the Turnaround Management Association
September 15, 2021
1min